Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A new role for an old actor

Nature Medicine volume 3, pages 1084–1085 (1997)Cite this article

Examining the contribution of the FDA to the development of gene therapeutics.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Epstein, S.L. Regulatory concerns in human gene therapy. Hum. Gene Ther. 2, 243–249 (1991).

    CAS  Article  Google Scholar 

  2. Walters, L. Human gene therapy: Ethics and public policy. Hum. Gene Ther. 2, 115–122 (1991).

    CAS  Article  Google Scholar 

  3. Wilson, C.A., Ng, T.-H. & Miller, A.E. Evaluation of recommendations for replication-competent retro-virus testing associated with use of retroviral vectors. Hum. Gene Ther. 8, 869–874 (1997).

    CAS  Article  Google Scholar 

  4. Crystal, R.G. The gene as the drug. Nature Med. 1, 15–7 (1995).

    CAS  Article  Google Scholar 

  5. Mamelok, R.D. in Clinical Pharmacology: Basic Principles in Therapeutics (eds. Melmon, K.L., Morrelli, H.F., Hoffman, B.B. & Nierenberg, D.W.) 911–921 (McGraw-Hill, Inc., New York, 1992).

    Google Scholar 

  6. Crystal, R.G. et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42–51 (1994).

    CAS  Article  Google Scholar 

  7. Wilson, J.M. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185–1187 (1996).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California, 94305–5332, USA

    John A. Wagner

  2. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Bethesda, Maryland, 20852–1448, USA

    Parris Burd

Authors
  1. John A. Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Parris Burd
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wagner, J., Burd, P. A new role for an old actor. Nat Med 3, 1084–1085 (1997). https://doi.org/10.1038/nm1097-1084

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1097-1084

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing